Volume 10, Issue 2 (2019)
JMBS 2019, 10(2): 255-261 |
Back to browse issues page
1- Cellular Sciences Institute (Royan), Institute of Biology and Technology of Stem Cell Academy, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran
2- Cellular Sciences Institute (Royan), Institute of Biology and Technology of Stem Cell Academy, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran, Cellular Sciences Institute (Royan), Institute of Biology and Technology of Stem Cell Academy, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran ,mebrahimi@royaninstitute.org
3- Genetics, Reproductive Biomedical Department, Institute of Biology and Technology of Stem Cell Academy, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran
2- Cellular Sciences Institute (Royan), Institute of Biology and Technology of Stem Cell Academy, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran, Cellular Sciences Institute (Royan), Institute of Biology and Technology of Stem Cell Academy, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran ,
3- Genetics, Reproductive Biomedical Department, Institute of Biology and Technology of Stem Cell Academy, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran
Abstract: (6470 Views)
Cancer stem cells are responsible for the formation the resistance to treatment, tumor relapse, and metastasis. miRNAs play an important role in the regulation of biological processes. Therefore, the purpose of this review is to candidate miRNAs that are involved in the regulation of all three properties including stemness , metastasis, and drug resistance and find their target genes and signaling pathways by using literature learning and data mining. The present systematic review is done to identify stemness -regulating miRNAs . By using CORMINE database, metastasis and drug resistance regulating miRNAs collected. Finally, we compared these three lists of miRNAs and found common miRNAs in these three properties. ONCO.IO database and KEGG pathway have been done to obtain the interaction between miRNA -miRNA target and cancer-related signaling pathway respectively. We collected 191 stemness -regulating miRNAs from 21 excluded studies. Based on CORMINE database, 161 miRNAs and 57 miRNAs had metastasis and stemness features respectively. We obtained 7 common miRNAs that 4 of them including has-miR-34a, has-miR-23a, has-miR-30a, has-miR-100 has a significant role for targeting signaling pathways involved in cancer and their most important targets regulate many processes of cells. These data suggest that three important properties can regulate by common miRNAs . Therefore, target these miRNAs or their targets can be helpful to stop tumor growth and metastasis and may be useful biomarkers for early detection of gastric cancer.
Subject:
Agricultural Biotechnology
Received: 2017/10/26 | Accepted: 2018/02/13 | Published: 2019/06/20
Received: 2017/10/26 | Accepted: 2018/02/13 | Published: 2019/06/20
References
1. NCD Management Unit. Cancer [Internet]. Geneva: World Health Organization; 2015 [cited 2016 Nov 24]. Available from: http://www.who.int/cancer/en/ [Link]
2. Stewart B, Wild CP. World cancer report. Lyon: International Agency for Research on Cancer; 2015. [Link]
3. Tan BT, Park CY, Ailles LE, Weissman IL. The cancer stem cell hypothesis: A work in progress. Lab Invest. 2006;86(12):1203-7. [Link] [DOI:10.1038/labinvest.3700488]
4. Han L, Shi S, Gong T, Zhang Z, Sun X. Cancer stem cells: Therapeutic implications and perspectives in cancer therapy. Acta Pharmaceutica Sinica B. 2013;3(2):65-75. [Link] [DOI:10.1016/j.apsb.2013.02.006]
5. Takahashi T, Saikawa Y, Kitagawa Y. Gastric cancer: Current status of diagnosis and treatment. Cancers (Basel). 2013;5(1):48-63. [Link] [DOI:10.3390/cancers5010048]
6. Fang X, Wei J, He X, An P, Wang H, Jiang L, et al. Landscape of dietary factors associated with risk of gastric cancer: A systematic review and dose-response meta-analysis of prospective cohort studies. Eur J Cancer. 2015;51(18):2820-32. [Link] [DOI:10.1016/j.ejca.2015.09.010]
7. Gao Y, Feng B, Han S, Zhang K, Chen J, Li C, et al. The roles of microRNA-141 in human cancers: From diagnosis to treatment. Cell Physiol Biochem. 2016;38(2):427-48. [Link] [DOI:10.1159/000438641]
8. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med. 2005;353(17):1768-71. [Link] [DOI:10.1056/NEJMp058190]
9. Sang Q, Yao Z, Wang H, Feng R, Wang H, Zhao X, et al. Identification of microRNAs in human follicular fluid: characterization of microRNAs that govern steroidogenesis in vitro and are associated with polycystic ovary syndrome in vivo. J Clin Endocrinol Metab. 2013;98(7):3068-79. [Link] [DOI:10.1210/jc.2013-1715]
10. Raza U, Zhang JD, Şahin Ö. MicroRNAs: Master regulators of drug resistance, stemness, and metastasis. J Mol Med (Berl). 2014;92(4):321-36. [Link] [DOI:10.1007/s00109-014-1129-2]
11. Zhou L, Liu F, Wang X, Ouyang G. The roles of microRNAs in the regulation of tumor metastasis. Cell Biosci. 2015;5:32. [Link] [DOI:10.1186/s13578-015-0028-8]
12. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011;17(2):211-5. [Link] [DOI:10.1038/nm.2284]
13. Magee P, Shi L, Garofalo M. Role of microRNAs in chemoresistance. Ann Transl Med. 2015;3(21):332. [Link]
14. Chou SM, Lee TS, Shao YE, Chen IF. Mining the breast cancer pattern using artificial neural networks and multivariate adaptive regression splines. Expert Syst Appl. 2004;27(1):133-42. [Link] [DOI:10.1016/j.eswa.2003.12.013]
15. Banwait JK, Bastola DR. Contribution of bioinformatics prediction in microRNA-based cancer therapeutics. Adv Drug Deliv Rev. 2015;81:94-103. [Link] [DOI:10.1016/j.addr.2014.10.030]
16. Zhang H, Li S, Yang J, Liu S, Gong X, Yu X. The prognostic value of miR-34a expression in completely resected gastric cancer: Tumor recurrence and overall survival. Int J Clin Exp Med. 2015;8(2):2635-41. [Link]
17. Liu G, Jiang C, Li D, Wang R, Wang W. MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer. Tumour Biol. 2014;35(10):9801-6. [Link] [DOI:10.1007/s13277-014-2273-6]
18. Zhang S, Chen P, Huang Z, Hu X, Chen M, Hu S, et al. Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a. Sci Rep. 2015;5:9787. [Link] [DOI:10.1038/srep09787]
19. Cao W, Yang W, Fan R, Li H, Jiang J, Geng M, et al. miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway. Tumour Biol. 2014;35(2):1287-95. [Link] [DOI:10.1007/s13277-013-1171-7]
20. Ji Q, Hao X, Meng Y, Zhang M, Desano J, Fan D, et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer. 2008;8:266. [Link] [DOI:10.1186/1471-2407-8-266]
21. Wang G, Liu G, Ye Y, Fu Y, Zhang X. Upregulation of miR-34a by diallyl disulfide suppresses invasion and induces apoptosis in SGC-7901 cells through inhibition of the PI3K/Akt signaling pathway. Oncol Lett. 2016;11(4):2661-7. [Link] [DOI:10.3892/ol.2016.4266]
22. Ma G, Dai W, Sang A, Yang X, Gao C. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer. Int J Clin Exp Pathol. 2014;7(12):8833-40. [Link]
23. An Y, Zhang Z, Shang Y, Jiang X, Dong J, Yu P, et al. miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2. Cell Death Dis. 2015;6:e1766. [Link] [DOI:10.1038/cddis.2015.123]
24. Li L, Zhang J, Pan Q, Lei C. MicroRNA-23a regulates cell migration and invasion by target PTEN in gastric cancer. Int J Clin Exp Pathol. 2016;9(2):877-87. [Link]
25. Chen Z, Liu X, Hu Z, Wang Y, Liu M, Liu X, et al. Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer. Oncol Lett. 2015;10(1):329-36. [Link] [DOI:10.3892/ol.2015.3179]
26. Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M, et al. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res. 2011;9(7):824-33. [Link] [DOI:10.1158/1541-7786.MCR-10-0529]
27. Zhao X, Yang L, Hu J. Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells. J Exp Clin Cancer Res. 2011;30(1):55. [Link] [DOI:10.1186/1756-9966-30-55]
28. Wang F, Li T, Zhang B, Li H, Wu Q, Yang L, et al. MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. Biochem Biophys Res Commun. 2013;434(3):688-94. [Link] [DOI:10.1016/j.bbrc.2013.04.010]
29. Li X, Zhang Y, Shi Y, Dong G, Liang J, Han Y, et al. MicroRNA‐107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer. J Cell Mol Med. 2011;15(9):1887-95. [Link] [DOI:10.1111/j.1582-4934.2010.01194.x]
30. Li F, Liu B, Gao Y, Liu Y, Xu Y, Tong W, et al. Upregulation of microRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1. FEBS Lett. 2014;588(4):538-44. [Link] [DOI:10.1016/j.febslet.2013.12.009]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |